EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

A novel compound heterozygous mutation (c.64G > A and c.506-1G > A) associated with congenital coagulation factor VII deficiency: a case report and literature review

Yu Jiao, Xiaoyi Lv, Xiaojing Yan

Annals of Hematology · 2025

DOI: 10.1007/s00277-025-06364-4 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Annals of Hematology, 2025. Verfasst von Yu Jiao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The First Hospital of China Medical University, 155 Nanjing North Street, Shenyang, Liaoning, 110000, China. Hauptthemen laut MEDLINE: Factor VII, Factor VII Deficiency, Heterozygote, Mutation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Department of Science and Technology of Liaoning Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Congenital factor VII (FVII) deficiency is a rare autosomal recessive bleeding disorder characterized by prolonged prothrombin time (PT) and reduced FVII coagulant activity (FVII: C). Here, we present the case of a middle-aged male patient with gastrointestinal bleeding, who exhibited prolonged PT and decreased FVII: C levels. Gene sequencing analysis revealed compound heterozygous mutations in the F7 gene: c.64G > A (p.V22I) and c.506-1G > A. Based on the laboratory results and gene sequencing, the patient was diagnosed as FVII deficiency. After adding recombinant activated FVII (rFVIIa) for several days, the laboratory indicators returned to normal and the bleeding symptoms were relieved. In subsequent validation studies, we also identified the c.506-1G > A mutation in his older sister and daughter. Importantly, this represents the first documented case where both mutations coexist concurrently. Additionally, our literature review reveals that approximately 50% of mutation types associated with congenital FVII deficiency are located on exon 9; however, there is no significant correlation between the reduction in FVII: C levels and severity of clinical symptoms based on EAHAD database analysis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Factor VIIFactor VII DeficiencyHeterozygoteMutationHumansMaleMiddle AgedFactor VIIaGastrointestinal HemorrhageRecombinant Proteins

Stichwörter der Autor:innen

Case reportCongenital factor VII deficiencyEAHADProthrombin time

Substanzen

Factor VIIFactor VIIarecombinant FVIIaRecombinant Proteins

Autor:innen und Institutionen

  • Department of Hematology, The First Hospital of China Medical University, 155 Nanjing North Street, Shenyang, Liaoning, 110000, China.
  • Department of Hematology, The First Hospital of China Medical University, 155 Nanjing North Street, Shenyang, Liaoning, 110000, China. yanxiaojing_pp@hotmail.com.

Förderung

  • Department of Science and Technology of Liaoning Province

Zitieren

APA

Jiao, Y., Lv, X., & Yan, X. (2025). A novel compound heterozygous mutation (c.64G > A and c.506-1G > A) associated with congenital coagulation factor VII deficiency: a case report and literature review. Annals of Hematology. https://doi.org/10.1007/s00277-025-06364-4

Vancouver

Jiao Y, Lv X, Yan X. A novel compound heterozygous mutation (c.64G > A and c.506-1G > A) associated with congenital coagulation factor VII deficiency: a case report and literature review. Annals of Hematology. 2025. doi:10.1007/s00277-025-06364-4

BibTeX
@article{Jiao2025,
  author = {Jiao, Yu and Lv, Xiaoyi and Yan, Xiaojing},
  title = {A novel compound heterozygous mutation (c.64G > A and c.506-1G > A) associated with congenital coagulation factor VII deficiency: a case report and literature review},
  journal = {Annals of Hematology},
  year = {2025},
  doi = {10.1007/s00277-025-06364-4}
}
Kostenlos starten →